# CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry

> **NCT01402661** · — · ENROLLING_BY_INVITATION · sponsor: **CorEvitas** · enrollment: 91758 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01402661
- **Lead sponsor:** CorEvitas
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2002-02
- **Primary completion:** 2100-12
- **Final completion:** 2100-12
- **Target enrollment:** 91758 (ESTIMATED)
- **Last updated:** 2025-10-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01402661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01402661, "CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01402661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*